Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
06/2005
06/08/2005EP1231925B1 Method and composition for the treatment of adenoviral ocular infections
06/08/2005EP1089735B1 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective nmda receptor antagonists
06/08/2005CN1625603A Genetic polymorphisms in the preprotachykinin gene
06/08/2005CN1625403A Remedies for glaucoma comprising bunazosin and prostaglandins
06/08/2005CN1625400A 2, 4-pyrimidinediamine compounds and their uses
06/08/2005CN1625395A Lutein/zeaxanthin for glare protection
06/08/2005CN1625393A Alpha 2 delta ligands to treat tinnitus
06/08/2005CN1625385A Lipase inhibiting composition
06/08/2005CN1623549A Eyedrops
06/08/2005CN1205207C Substituted indolealkanoic acids
06/08/2005CN1205181C Matrix metalloproteinase inhibitors
06/08/2005CN1204922C Ophthalmic compositions
06/08/2005CN1204919C Long-acting intra-ocular release system of cyclosporin
06/08/2005CN1204908C Chinese medicine for treating deafness and tinnitus and its prepn method
06/07/2005US6903215 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
06/07/2005US6903188 Isolated functional derivative of an Mts protein that is preferably a multimeric protein complex.
06/07/2005US6903187 Structural modification of clostridal neurotoxins including addition or deletion of a leucine-based motif to treat biological disorders include treating autonomic disorders, neuromuscular disorders and pain
06/07/2005US6903131 Administering to a patient an antiangiogenesis or anticancer agent (N,N-disubstituted-3,4-diamino-2,4-dione-pyrroline derivatives for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer
06/07/2005US6903115 Bipiperidine compounds
06/07/2005US6903088 Compounds which inhibit leukocyte adhesion mediated by VLA-4
06/07/2005US6903087 Pyrido cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
06/07/2005US6902908 Polypeptides, fusion proteins; includes production and use recombinant expression constructs having regulated promoter; mitochondria
06/07/2005US6902731 Transcription factors; for arterial administration via stent
06/07/2005CA2348026C Antibodies against semp1, methods for their production and uses thereof
06/07/2005CA2281090C Sulfonamide compounds and salts for treatment of endothelin-mediated disorders
06/02/2005WO2003075847A3 NOVEL CURCUMINOID-FACTOR VIIa CONSTRUCTS AS SUPPRESSORS OF TUMOR GROWTH AND ANGIOGENESIS
06/02/2005US20050119499 Cyclic hemiacetal derivative and use thereof
06/02/2005US20050119334 Neurodegenerative disease; Alzheimer's and Parkinson's disease
06/02/2005US20050119291 Pyrimidine compounds
06/02/2005US20050119280 1-[alkyl 1-[heteroaryl )alkyl] and 1-[ aryl) alkyl]-7-( pyrimidin-4-yl) imadazo [1,2-a] pyrimidin-5(1h)-one derivatives
06/02/2005US20050119271 Pyrimidine A2B selective antagonist compounds, their synthesis and use
06/02/2005US20050119267 Diazabicyclo alkane derivatives with nk1 antagonistic activity
06/02/2005US20050119250 Amino-derivatives as novel inhibitors of histone deacetylase
06/02/2005US20050119219 Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring
06/02/2005US20050119213 Vascular therapeutics
06/02/2005US20050118715 Modulation of stem and progenitor cell differentiation, assays, and uses thereof
06/02/2005US20050118585 Using allelic variation in bone morphogenic signaling family proteins as diagnostic tool in detection of vision defcets
06/02/2005US20050118242 Using testosterone; topical applying to skins
06/02/2005US20050118189 Mutant Hin47 protein with decreased protease activity, and a high molecular weight protein of a strain of non-typeable Haemophilus influenzae; may be combined with diphtheria or tetanus toxoids, pertussis antigens or non-virulent poliovirus; immunization; otitis media
06/02/2005CA2546013A1 Novel prostamides for the treatment of glaucoma and related diseases
06/02/2005CA2545514A1 Combination of a dpp iv inhibitor and an antiobesity or appetite regulating agent
06/02/2005CA2544230A1 Combinations of at1-antagonists, amiloride or triamterine, and a diuretic
06/01/2005EP1535915A1 Furan or thiophene derivative and medicinal use thereof
06/01/2005EP1535891A1 Remedy
06/01/2005EP1535617A1 Remedy or preventive for keratoconjunctival epithelial cell injury
06/01/2005EP1535512A1 DISEASE MODEL ANIMAL CARRYING FOREIGN PPARa GENE TRANSFERRED THEREINTO AND USE THEREOF
06/01/2005EP1535065A2 Neuroprotective synergy of erythropoietin and insulin-like growth factor
06/01/2005EP1534847A1 Retroviral vector and stable packaging cell lines
06/01/2005EP1534695A2 Tyrosine kinase inhibitors
06/01/2005EP1534687A1 Pyrimidine compounds
06/01/2005EP1534681A1 Substituted quinoline ccr5 receptor antagonists
06/01/2005EP1534668A1 Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid
06/01/2005EP1534667A1 Muscarinic agonists
06/01/2005EP1534663A1 N-bridged selective androgen receptor modulators and methods of use thereof
06/01/2005EP1534391A1 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
06/01/2005EP1534332A2 Antibodies and uses thereof
06/01/2005EP1534331A2 Membrane associated tumor endothelium markers
06/01/2005EP1534300A2 3, 10, and 12a substituted tetracycline compounds
06/01/2005EP1534290A2 Novel inhibitors of kinases
06/01/2005EP1534282A2 Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases
06/01/2005EP1534278A2 Nitrosated proton pump inhibitors, compositions and methods of use
06/01/2005EP1534275A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals
06/01/2005EP1534264A2 Compounds that modulate the activity of ptp-1b and tc-ptp
06/01/2005EP1534261A2 Epa and dha enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia
06/01/2005EP1534256A2 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier
06/01/2005EP1534250A2 Electrospun amorphous pharmaceutical compositions
06/01/2005EP1534202A1 Ophthalmic drug delivery system
06/01/2005EP1411926B1 Integrin inhibitors for the treatment of eye diseases
06/01/2005EP1404330B1 Substituted 8-arylquinoline pde4 inhibitors
06/01/2005EP1268465B1 Triarylimidazole derivatives as cytokine inhibitors
06/01/2005EP1233951B1 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors
06/01/2005EP1228030B1 Benzenoid derivatives of 15-hydroxyeicosatetraenoic acid and methods of their use in treating dry eye disorders
06/01/2005EP1178977B1 Ion channel modulating agents
06/01/2005EP1058553B1 Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytopathy
06/01/2005CN1622830A Peptide-based compounds
06/01/2005CN1622812A Prophylactic and therapeutic treatment of infectious and other diseases with immune effect compound
06/01/2005CN1621059A Chinese traditional medicine composition for refreshing and improving vision acuity
06/01/2005CN1204138C Pyrazolo [4, 3-d] pyrimidine derivs.
06/01/2005CN1203852C Valdecoxib compositions
06/01/2005CN1203849C Remedy for keratoconjunctival diseases
06/01/2005CN1203842C Arificial tear solution
05/2005
05/31/2005US6900336 8-aza-11-deoxy prostaglandin analogues
05/31/2005US6900334 Antiallergens; autoimmune diseases
05/31/2005US6900309 Aminocarbonylation reaction of a adenosine compound containing purine base and pentofuranosyl sugar and a leaving group at 2 position of purine ring, with an amine compound in presence of carbon monoxide and suitable coupling catalyst
05/31/2005US6900243 Phenylheteroalkylamine derivatives
05/31/2005US6900232 For therapy of tumor metastasis, solid tumor growth (neoplasia), osteoporosis, Paget's disease, humoral hypercalcemia of malignancy, osteopenia, angiogenesis, including tumor angiogenesis and lymphangiogenesis
05/31/2005US6900214 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
05/31/2005US6900201 N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
05/31/2005US6900200 Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
05/31/2005CA2324343C C11 oxymyl and hydroxylamino prostaglandins useful as medicaments
05/26/2005US20050113577 Such as hydrochloride salt 3-[5-(4-methanesulfonyl-piperazin-1-yl-methyl)-1H-indol-2-yl]-1H-quinolin-2-one; signal transduction; for treatment of angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, and inflammatory diseases
05/26/2005US20050113451 7-acetamidinyl derivatives
05/26/2005US20050113416 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
05/26/2005US20050113414 1-[1-((E)-1-Cyclooct-1-enyl)methylpiperidin-4-yl]-3-(3,4-dichlorophenyl)-urea; potent and selective modulators of CXCR3, a chemokine receptor; antagonists; treatment of conditions involving inappropriate T-cell trafficking; antiinflammatory, -arthritic agents, autoimmune diseases; antiallergens
05/26/2005US20050113377 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation and their use as cyclooxygenase, 2 (COX-2) inhibitors
05/26/2005US20050113361 Amide derivatives as NMDA receptor antagonists
05/26/2005US20050113360 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one
05/26/2005US20050113359 NMDA (N-methyl-D-aspartate) receptors; eg 1-[4-(4-fluoro-benzyl)-piperidin-1-yl]-1-(6-hydroxy-1H-indole-2-yl)methanone
05/26/2005US20050113358 Enzyme inhibitors for erectile dysfunction and sexual disorders
05/26/2005US20050113357 Cholinergic agents such as 3-[3-(4-methoxypiperidine)-1-yl-propyl]-1H-indole; for therapy of cognitive dysfunction, forgetfulness, confusion, memory loss, attention deficits, deficits in visual perception, depression, pain, sleep disorders, and psychosis
1 ... 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 ... 531